Thursday, December 02, 2021


Cuba produces 30 million doses of Abdala Covid-19 vaccine

Cuba produces 30 million doses of Abdala Covid-19 vaccine

Havana, Sep 26 (Prensa Latina) Cuba has produced 30 million doses of the Abdala Covid-19 vaccine, developed by the Center for Genetic Engineering and Biotechnology (CIGB), the institution confirmed.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

‘Cuba has produced 30 million doses of #Abdala Covid-19 vaccine for the immunization of the people. #CubaEsCiencia (Cuba is science) #CubaEsSalud (Cuba is health) #SiemprePorLaVida (Always for life),’ the CIGB published on Twitter.

In another tweet, the institution explained that this production will guarantee the immunization of the population over 19 years of age, which includes pregnant women, breastfeeding mothers, people with transplants, adolescents and young people in senior years of the national education school system.

Abdala, the first vaccine in Cuba and Latin America, showed an efficacy of 90 percent in critically ill patients and against the Delta variant of the SARS-CoV-2 coronavirus, and 92.28 percent against the symptomatic disease with a scheme of three doses at 14-day intervals.

On the other hand, the CIGB reported that 120,000 doses of the vaccine without thiomersal were delivered to vaccinate people allergic to that medication in the capital and other provinces of the country.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.